Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$6.96 - $9.26 $259,719 - $345,546
-37,316 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$5.71 - $7.39 $7,000 - $9,060
1,226 Added 3.4%
37,316 $276,000
Q2 2021

Aug 11, 2021

BUY
$6.1 - $7.58 $128,343 - $159,483
21,040 Added 139.8%
36,090 $227,000
Q4 2019

Feb 13, 2020

BUY
$4.34 - $5.86 $65,317 - $88,193
15,050 New
15,050 $72,000

Others Institutions Holding SIGA

About SIGA TECHNOLOGIES INC


  • Ticker SIGA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 73,024,096
  • Market Cap $432M
  • Description
  • SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla T...
More about SIGA
Track This Portfolio

Track Mackenzie Financial Corp Portfolio

Follow Mackenzie Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mackenzie Financial Corp with notifications on news.